WMSA
AMLX icon

Weiss Multi-Strategy Advisers’s Amylyx Pharmaceuticals AMLX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,054
Closed -$257K – 536
2023
Q3 		$257K Sell
14,054
-1,657
-11% -$35K 0.01% 515
2023
Q2 		$339K Sell
15,711
-38,343
-71% -$1.04M 0.01% 592
2023
Q1 		$1.59M Buy
+54,054
New +$1.88M 0.04% 456

Other funds holding AMLX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AMLX Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Amylyx Pharmaceuticals (AMLX) in Q4 2023, closing a stake of 14,054 shares — an estimated $257K sold.

Weiss Multi-Strategy Advisers first reported a position in AMLX in Q1 2023 and held it in 3 quarters. The position peaked at $1.59M in Q1 2023. 178 funds tracked by Wall St. Rank hold AMLX as of Q4 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Amylyx Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 14,054 Amylyx Pharmaceuticals shares in Q4 2023, an estimated $257K.
  • Weiss Multi-Strategy Advisers first reported a position in Amylyx Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's Amylyx Pharmaceuticals position peaked at $1.59M in Q1 2023.
  • 178 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.